Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

Go ahead and say yes to the accent wall—the right one will ensure your home makes an excellent first impression! Whether you’re a minimalist who gravitates toward neutral paint colors, a maximalist ...

Bringing together traditional Chinese medicine and contemporary medicine could improve outcomes for patients with chronic disease. In this Q&A, Lidian Chen, professor and chief physician at Fujian ...